METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS
FIELD: medicine. ^ SUBSTANCE: invention refers to medicine and concerns methods of neural disorder treatment with introducing hematopoietic growth factors. Substance of the invention includes G-CSF or its functionally active version 90% identical to human G-CSF sequence presented in SEQ ID NO:28 to...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; rus |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | VEBER DANIEHLA GASSLER NIKOLAUS SHNAJDER ARMIN KOLL'MAR RAJNER SHVAB SHTEFAN KRJUGER KAROLA MAURER MARTIN SHEBITTS VOL'F-RJUDIGER ZOMMER KLEMENS |
| description | FIELD: medicine. ^ SUBSTANCE: invention refers to medicine and concerns methods of neural disorder treatment with introducing hematopoietic growth factors. Substance of the invention includes G-CSF or its functionally active version 90% identical to human G-CSF sequence presented in SEQ ID NO:28 to be applied in therapy of amyotrophic lateral sclerosis. ^ EFFECT: benefit of the invention consists in neuroprotection of disease-related nerve cells. ^ 2 cl, 38 ex, 1 tbl, 41 dwg
Изобретение относится к области медицины и касается способов лечения неврологических состояний с применением введения гематопоэтических факторов роста. Сущность изобретения включает G-CSF или его функционально активный вариант, который на 90% идентичен последовательности G-CSF человека, представленной в SEQ ID NO: 28 для применения в способе лечения амиотрофического бокового склероза. Преимущество изобретения заключается в создании нейропротекции вовлеченных в заболевание нейронных клеток. 1 з.п. ф-лы, 1 табл. 41 ил. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2353385C2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2353385C2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2353385C23</originalsourceid><addsrcrecordid>eNqNyrEKwjAQgOEsDqK-w72AS0PBNSSXJtDk5HKhYykSJ9FCfX908AGc_uH792pMKIFcAfKQsbIZwcVC7JBBGI0kzAJTlAC1xDxAwGSErhRRooWBafqSN1aIy1Ht7stja6dfDwo8ig3ntr7mtq3LrT3be-ba6V7rS287_cfyAY79Lhk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS</title><source>esp@cenet</source><creator>VEBER DANIEHLA ; GASSLER NIKOLAUS ; SHNAJDER ARMIN ; KOLL'MAR RAJNER ; SHVAB SHTEFAN ; KRJUGER KAROLA ; MAURER MARTIN ; SHEBITTS VOL'F-RJUDIGER ; ZOMMER KLEMENS</creator><creatorcontrib>VEBER DANIEHLA ; GASSLER NIKOLAUS ; SHNAJDER ARMIN ; KOLL'MAR RAJNER ; SHVAB SHTEFAN ; KRJUGER KAROLA ; MAURER MARTIN ; SHEBITTS VOL'F-RJUDIGER ; ZOMMER KLEMENS</creatorcontrib><description>FIELD: medicine. ^ SUBSTANCE: invention refers to medicine and concerns methods of neural disorder treatment with introducing hematopoietic growth factors. Substance of the invention includes G-CSF or its functionally active version 90% identical to human G-CSF sequence presented in SEQ ID NO:28 to be applied in therapy of amyotrophic lateral sclerosis. ^ EFFECT: benefit of the invention consists in neuroprotection of disease-related nerve cells. ^ 2 cl, 38 ex, 1 tbl, 41 dwg
Изобретение относится к области медицины и касается способов лечения неврологических состояний с применением введения гематопоэтических факторов роста. Сущность изобретения включает G-CSF или его функционально активный вариант, который на 90% идентичен последовательности G-CSF человека, представленной в SEQ ID NO: 28 для применения в способе лечения амиотрофического бокового склероза. Преимущество изобретения заключается в создании нейропротекции вовлеченных в заболевание нейронных клеток. 1 з.п. ф-лы, 1 табл. 41 ил.</description><language>eng ; rus</language><subject>HUMAN NECESSITIES ; HYGIENE ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; PHYSICS ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; TESTING</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090427&DB=EPODOC&CC=RU&NR=2353385C2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20090427&DB=EPODOC&CC=RU&NR=2353385C2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VEBER DANIEHLA</creatorcontrib><creatorcontrib>GASSLER NIKOLAUS</creatorcontrib><creatorcontrib>SHNAJDER ARMIN</creatorcontrib><creatorcontrib>KOLL'MAR RAJNER</creatorcontrib><creatorcontrib>SHVAB SHTEFAN</creatorcontrib><creatorcontrib>KRJUGER KAROLA</creatorcontrib><creatorcontrib>MAURER MARTIN</creatorcontrib><creatorcontrib>SHEBITTS VOL'F-RJUDIGER</creatorcontrib><creatorcontrib>ZOMMER KLEMENS</creatorcontrib><title>METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS</title><description>FIELD: medicine. ^ SUBSTANCE: invention refers to medicine and concerns methods of neural disorder treatment with introducing hematopoietic growth factors. Substance of the invention includes G-CSF or its functionally active version 90% identical to human G-CSF sequence presented in SEQ ID NO:28 to be applied in therapy of amyotrophic lateral sclerosis. ^ EFFECT: benefit of the invention consists in neuroprotection of disease-related nerve cells. ^ 2 cl, 38 ex, 1 tbl, 41 dwg
Изобретение относится к области медицины и касается способов лечения неврологических состояний с применением введения гематопоэтических факторов роста. Сущность изобретения включает G-CSF или его функционально активный вариант, который на 90% идентичен последовательности G-CSF человека, представленной в SEQ ID NO: 28 для применения в способе лечения амиотрофического бокового склероза. Преимущество изобретения заключается в создании нейропротекции вовлеченных в заболевание нейронных клеток. 1 з.п. ф-лы, 1 табл. 41 ил.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PHYSICS</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQgOEsDqK-w72AS0PBNSSXJtDk5HKhYykSJ9FCfX908AGc_uH792pMKIFcAfKQsbIZwcVC7JBBGI0kzAJTlAC1xDxAwGSErhRRooWBafqSN1aIy1Ht7stja6dfDwo8ig3ntr7mtq3LrT3be-ba6V7rS287_cfyAY79Lhk</recordid><startdate>20090427</startdate><enddate>20090427</enddate><creator>VEBER DANIEHLA</creator><creator>GASSLER NIKOLAUS</creator><creator>SHNAJDER ARMIN</creator><creator>KOLL'MAR RAJNER</creator><creator>SHVAB SHTEFAN</creator><creator>KRJUGER KAROLA</creator><creator>MAURER MARTIN</creator><creator>SHEBITTS VOL'F-RJUDIGER</creator><creator>ZOMMER KLEMENS</creator><scope>EVB</scope></search><sort><creationdate>20090427</creationdate><title>METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS</title><author>VEBER DANIEHLA ; GASSLER NIKOLAUS ; SHNAJDER ARMIN ; KOLL'MAR RAJNER ; SHVAB SHTEFAN ; KRJUGER KAROLA ; MAURER MARTIN ; SHEBITTS VOL'F-RJUDIGER ; ZOMMER KLEMENS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2353385C23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2009</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PHYSICS</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>VEBER DANIEHLA</creatorcontrib><creatorcontrib>GASSLER NIKOLAUS</creatorcontrib><creatorcontrib>SHNAJDER ARMIN</creatorcontrib><creatorcontrib>KOLL'MAR RAJNER</creatorcontrib><creatorcontrib>SHVAB SHTEFAN</creatorcontrib><creatorcontrib>KRJUGER KAROLA</creatorcontrib><creatorcontrib>MAURER MARTIN</creatorcontrib><creatorcontrib>SHEBITTS VOL'F-RJUDIGER</creatorcontrib><creatorcontrib>ZOMMER KLEMENS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VEBER DANIEHLA</au><au>GASSLER NIKOLAUS</au><au>SHNAJDER ARMIN</au><au>KOLL'MAR RAJNER</au><au>SHVAB SHTEFAN</au><au>KRJUGER KAROLA</au><au>MAURER MARTIN</au><au>SHEBITTS VOL'F-RJUDIGER</au><au>ZOMMER KLEMENS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS</title><date>2009-04-27</date><risdate>2009</risdate><abstract>FIELD: medicine. ^ SUBSTANCE: invention refers to medicine and concerns methods of neural disorder treatment with introducing hematopoietic growth factors. Substance of the invention includes G-CSF or its functionally active version 90% identical to human G-CSF sequence presented in SEQ ID NO:28 to be applied in therapy of amyotrophic lateral sclerosis. ^ EFFECT: benefit of the invention consists in neuroprotection of disease-related nerve cells. ^ 2 cl, 38 ex, 1 tbl, 41 dwg
Изобретение относится к области медицины и касается способов лечения неврологических состояний с применением введения гематопоэтических факторов роста. Сущность изобретения включает G-CSF или его функционально активный вариант, который на 90% идентичен последовательности G-CSF человека, представленной в SEQ ID NO: 28 для применения в способе лечения амиотрофического бокового склероза. Преимущество изобретения заключается в создании нейропротекции вовлеченных в заболевание нейронных клеток. 1 з.п. ф-лы, 1 табл. 41 ил.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; rus |
| recordid | cdi_epo_espacenet_RU2353385C2 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING |
| title | METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T15%3A54%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VEBER%20DANIEHLA&rft.date=2009-04-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2353385C2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |